🔴 Adaptive Biotechnologies is trading 4.02% down with no clear company-specific catalyst

Adaptive Biotechnologies is trading 4.02% down now at $25.43, with no clear company-specific announcement or catalyst identified for the October 12, 2026 decline.

• Recent analyst updates were generally positive, offering no obvious explanation for the drop.
• The broader market was mixed: the Nasdaq fell 0.41% and the S&P 500 fell 0.05%, while the Dow rose 0.42%. These modest moves do not establish a market-wide cause for the stock’s larger decline.